{"id":"https://openalex.org/W2140965629","doi":"https://doi.org/10.1016/s0140-6736(09)60506-7","title":"Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor \u03b1 inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial","display_name":"Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor \u03b1 inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial","publication_year":2009,"publication_date":"2009-06-27","ids":{"openalex":"https://openalex.org/W2140965629","doi":"https://doi.org/10.1016/s0140-6736(09)60506-7","mag":"2140965629","pmid":"https://pubmed.ncbi.nlm.nih.gov/19560810"},"language":"en","primary_location":{"id":"doi:10.1016/s0140-6736(09)60506-7","doi":"https://doi.org/10.1016/s0140-6736(09)60506-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0140-6736(09)60506-7","pdf_url":null,"source":{"id":"https://openalex.org/S49861241","display_name":"The Lancet","issn_l":"0099-5355","issn":["0099-5355","0140-6736","1474-547X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111657027","display_name":"Josef S Smolen","orcid":"https://orcid.org/0000-0002-8899-9087","observed_orcids":["https://orcid.org/0000-0002-8899-9087"]},"institutions":[{"id":"https://openalex.org/I4210089076","display_name":"Klinik Hietzing","ror":"https://ror.org/00621wh10","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210089076","https://openalex.org/I4210117134"]},{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":true,"raw_author_name":"Josef S Smolen","raw_affiliation_strings":["Medical University of Vienna and Hietzing Hospital, Division of Rheumatology, Department of Internal Medicine III, Vienna, Austria. josef.smolen@wienkav.at","Medical University of Vienna and Hietzing Hospital, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Vienna and Hietzing Hospital, Division of Rheumatology, Department of Internal Medicine III, Vienna, Austria. josef.smolen@wienkav.at","institution_ids":["https://openalex.org/I4210089076","https://openalex.org/I76134821"]},{"raw_affiliation_string":"Medical University of Vienna and Hietzing Hospital, Vienna, Austria","institution_ids":["https://openalex.org/I4210089076","https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028063859","display_name":"Jonathan Kay","orcid":"https://orcid.org/0000-0002-8970-4260","observed_orcids":["https://orcid.org/0000-0002-8970-4260"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Kay","raw_affiliation_strings":["Massachusetts General Hospital and Havard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital and Havard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051248102","display_name":"Mittie K. Doyle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mittie K Doyle","raw_affiliation_strings":["Centocor Research and Development, Malvern, PA, USA","University of Pennsylvania, School of Medicine, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development, Malvern, PA, USA","institution_ids":[]},{"raw_affiliation_string":"University of Pennsylvania, School of Medicine, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000282057","display_name":"Robert Landew\u00e9","orcid":"https://orcid.org/0000-0002-0577-6620","observed_orcids":["https://orcid.org/0000-0002-0577-6620"]},"institutions":[{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2800191616"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Robert Landew\u00e9","raw_affiliation_strings":["University Hospital Maastricht, Maastricht, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Maastricht, Maastricht, Netherlands","institution_ids":["https://openalex.org/I2800191616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052273654","display_name":"Eric L. Matteson","orcid":"https://orcid.org/0000-0002-9866-0124","observed_orcids":["https://orcid.org/0000-0002-9866-0124"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric L Matteson","raw_affiliation_strings":["Mayo Clinic, Rochester, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112722772","display_name":"J\u00fcrgen Wollenhaupt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101674","display_name":"Sch\u00f6n Klinik Hamburg Eilbek","ror":"https://ror.org/00pz61m54","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210088209","https://openalex.org/I4210101674"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"J\u00fcrgen Wollenhaupt","raw_affiliation_strings":["Klinik Eibek, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Klinik Eibek, Hamburg, Germany","institution_ids":["https://openalex.org/I4210101674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055224792","display_name":"NORMAN B. GAYLIS","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095528","display_name":"Arthritis and Rheumatic Disease Specialties","ror":"https://ror.org/00n3baz54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210095528"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Norman Gaylis","raw_affiliation_strings":["Arthritis and Rheumatic Disease Specialties, Aventura, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arthritis and Rheumatic Disease Specialties, Aventura, FL, USA","institution_ids":["https://openalex.org/I4210095528"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028490996","display_name":"Frederick T. Murphy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112965","display_name":"Altoona Center for Clinical Research","ror":"https://ror.org/022q8ez38","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210112965"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frederick T Murphy","raw_affiliation_strings":["Altoona Center for Clinical Research, Duncansville, PA, USA","University of Pennsylvania, School of Medicine, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Altoona Center for Clinical Research, Duncansville, PA, USA","institution_ids":["https://openalex.org/I4210112965"]},{"raw_affiliation_string":"University of Pennsylvania, School of Medicine, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113899062","display_name":"Jeffrey Neal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey S Neal","raw_affiliation_strings":["Bluegrass Community Research, Lexington, KY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bluegrass Community Research, Lexington, KY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025049914","display_name":"Yiying Zhou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yiying Zhou","raw_affiliation_strings":["Centocor Research and Development, Malvern, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development, Malvern, PA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066635109","display_name":"Sudha Visvanathan","orcid":"https://orcid.org/0000-0002-1170-9272","observed_orcids":["https://orcid.org/0000-0002-1170-9272"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sudha Visvanathan","raw_affiliation_strings":["Centocor Research and Development, Malvern, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development, Malvern, PA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030325032","display_name":"Elizabeth C. Hsia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth C Hsia","raw_affiliation_strings":["Centocor Research and Development, Malvern, PA, USA","University of Pennsylvania, School of Medicine, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development, Malvern, PA, USA","institution_ids":[]},{"raw_affiliation_string":"University of Pennsylvania, School of Medicine, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103435269","display_name":"Mahboob U. Rahman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mahboob U Rahman","raw_affiliation_strings":["Centocor Research and Development, Malvern, PA, USA","University of Pennsylvania, School of Medicine, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development, Malvern, PA, USA","institution_ids":[]},{"raw_affiliation_string":"University of Pennsylvania, School of Medicine, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5111657027"],"corresponding_institution_ids":["https://openalex.org/I4210089076","https://openalex.org/I76134821"],"apc_list":{"value":7890,"currency":"USD","value_usd":7890},"apc_paid":null,"fwci":39.1188,"has_fulltext":false,"cited_by_count":526,"citation_normalized_percentile":{"value":0.99905273,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"374","issue":"9685","first_page":"210","last_page":"221"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/golimumab","display_name":"golimumab","score":0.9369999766349792},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9919999837875366},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.9120000004768372},{"id":"https://openalex.org/keywords/treatment-refractory-rheumatoid-arthritis","display_name":"treatment-refractory rheumatoid arthritis","score":0.6800000071525574},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.8169999718666077},{"id":"https://openalex.org/keywords/salvage-therapy","display_name":"salvage therapy","score":0.7630000114440918},{"id":"https://openalex.org/keywords/acr20-response","display_name":"ACR20 response","score":0.8849999904632568},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4880000054836273},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5960000157356262},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.47600001096725464},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.44200000166893005},{"id":"https://openalex.org/keywords/tender-and-swollen-joint-count","display_name":"swollen and tender joint count","score":0.6370000243186951},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.37299999594688416},{"id":"https://openalex.org/keywords/sulfasalazine","display_name":"sulfasalazine","score":0.578000009059906}],"concepts":[{"id":"https://openalex.org/C2781290027","wikidata":"https://www.wikidata.org/wiki/Q413879","display_name":"Golimumab","level":4,"score":0.9811685085296631},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9130804538726807},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.8798134326934814},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7375367879867554},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6671891808509827},{"id":"https://openalex.org/C2779123688","wikidata":"https://www.wikidata.org/wiki/Q421094","display_name":"Hydroxychloroquine","level":5,"score":0.5880962610244751},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.5283932089805603},{"id":"https://openalex.org/C2779722408","wikidata":"https://www.wikidata.org/wiki/Q1536078","display_name":"TNF inhibitor","level":4,"score":0.4804077446460724},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.4751672148704529},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.46632176637649536},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.44609737396240234},{"id":"https://openalex.org/C2777226972","wikidata":"https://www.wikidata.org/wiki/Q415343","display_name":"Etanercept","level":3,"score":0.3550281524658203},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.33899733424186707},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.33870914578437805},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.062275975942611694},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068800","descriptor_name":"Etanercept","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068879","descriptor_name":"Adalimumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012449","descriptor_name":"Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018124","descriptor_name":"Receptors, Tumor Necrosis Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1016/s0140-6736(09)60506-7","doi":"https://doi.org/10.1016/s0140-6736(09)60506-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0140-6736(09)60506-7","pdf_url":null,"source":{"id":"https://openalex.org/S49861241","display_name":"The Lancet","issn_l":"0099-5355","issn":["0099-5355","0140-6736","1474-547X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet","raw_type":"journal-article"},{"id":"pmid:19560810","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19560810","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lancet (London, England)","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/0c960e75-1cf6-4bcc-9546-6428b081c7ad","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/0c960e75-1cf6-4bcc-9546-6428b081c7ad","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Smolen, J S, Kay, J, Doyle, M K, Landew\u00e9, R, Matteson, E L, Wollenhaupt, J, Gaylis, N, Murphy, F T, Neal, J S, Zhou, Y, Visvanathan, S, Hsia, E C, Rahman, M U & AUTHOR GROUP 2009, 'Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial', Lancet, vol. 374, no. 9685, pp. 210-221. https://doi.org/10.1016/S0140-6736(09)60506-7","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/1fabf253-ff54-4d9c-9b81-e5d1a3bf2a98","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/golimumab-in-patients-with-active-rheumatoid-arthritis-after-treatment-with-tumour-necrosis-factor-alpha-inhibitors-goafter-study-a-multicentre-randomised-doubleblind-placebocontrolled-phase-iii-trial(1fabf253-ff54-4d9c-9b81-e5d1a3bf2a98).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Lancet, 374(9685), 210 - 221. Elsevier Limited","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.5799999833106995,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W1492940207","https://openalex.org/W1604679297","https://openalex.org/W1898024773","https://openalex.org/W1979364075","https://openalex.org/W1985004174","https://openalex.org/W1985763670","https://openalex.org/W1996389186","https://openalex.org/W1996472975","https://openalex.org/W2014709373","https://openalex.org/W2015215846","https://openalex.org/W2024644107","https://openalex.org/W2036369606","https://openalex.org/W2038962823","https://openalex.org/W2063931484","https://openalex.org/W2073972803","https://openalex.org/W2077158310","https://openalex.org/W2098767548","https://openalex.org/W2099559598","https://openalex.org/W2099680326","https://openalex.org/W2100974168","https://openalex.org/W2108650270","https://openalex.org/W2108779144","https://openalex.org/W2110177517","https://openalex.org/W2111153776","https://openalex.org/W2116843833","https://openalex.org/W2120332428","https://openalex.org/W2124670599","https://openalex.org/W2133028044","https://openalex.org/W2143835145","https://openalex.org/W2150952126","https://openalex.org/W2152348310","https://openalex.org/W2152721471","https://openalex.org/W2158058290","https://openalex.org/W2159106700","https://openalex.org/W2163204760","https://openalex.org/W2168792642","https://openalex.org/W2341953096","https://openalex.org/W2418970185","https://openalex.org/W6717562954"],"related_works":["https://openalex.org/W2147681024","https://openalex.org/W1981553585","https://openalex.org/W2118761321","https://openalex.org/W2109655434","https://openalex.org/W7000686995","https://openalex.org/W1988975600","https://openalex.org/W2110736574","https://openalex.org/W1983498156","https://openalex.org/W2121667395","https://openalex.org/W4283712934"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":17},{"year":2022,"cited_by_count":21},{"year":2021,"cited_by_count":22},{"year":2020,"cited_by_count":25},{"year":2019,"cited_by_count":24},{"year":2018,"cited_by_count":26},{"year":2017,"cited_by_count":37},{"year":2016,"cited_by_count":33},{"year":2015,"cited_by_count":53},{"year":2014,"cited_by_count":39},{"year":2013,"cited_by_count":41},{"year":2012,"cited_by_count":36}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}